New findings in pharmacological effects induced by antihistamines: From PET studies to knock-out mice

Clinical and Experimental Allergy, Supplement

Volumn 29, Issue 3, 1999, Pages 29-36

  Yanai, K ^a   Okamura, N ^b   Tagawa, M ^a   Itoh, M ^b   Watanabe, T ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Allergic rhinitis; Knock out mice; PET; Sleep wake cycle

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; AZELASTINE; CARBON 11; CHLORPHENIRAMINE; DOXEPIN; EPINASTINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; KETOTIFEN; MEPYRAMINE; MEQUITAZINE; OXATOMIDE; PLACEBO; TERFENADINE; TRITIUM;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AROUSAL; ARTICLE; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENE TARGETING; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NOCICEPTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; SLEEP WAKING CYCLE; SOMNOLENCE; VISUAL DISCRIMINATION;

EID: 0032802385     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00008.x-i1     Document Type: Article

References (33)

1. 1-receptor-antagonist drugs. N Engl J Pharmacol 1994; 330:1663-70.
2. Nicholson AN. Antihistamines and sedation. Lancet 1983; ii:211-212.
3. Adelsberg BR. Sedation and performance issues in the treatment of allergic conditions. Arch Int Med 1997; 157:494-500.
4. Nolen TM. Sedative effects of antihistamines: safety, performance, learning, and quality of life. Clin Ther 1997; 19:39-55.
5. 1-anatgonists. Prog Neurobiol 1997; 52:145-57.
6. 1 receptor antagonists. Ann Allergy Asthma Immunol 1995; 74:419-26.
7. 1 receptors in complex partial seizure. Lancet 1993; 341:238.
8. Yokoyama H, Iinuma K, Yanai K, Watanabe T, Sakurai E, Onodera K. Proconvulsant effect of ketotifen, a histamine H1 antagonist, confirmed by the use of d-chlorpheniramine with monitoring electroencephalography. Meth Find Exp Clin Pharmacol 1993; 15:183-8.
9. Churchill JA, Gammon GD .The effect of antihistaminic drugs on convulsive seizures. J Am Med Assoc 1949; 141:18-21.
10. Dailey JW, Naritoku DK. Antidepressants and seizures: clinical anecdotes overshadow neuroscience. Biochem Pharmacol 1996; 52:1323-9.
11. 11C]doxepin and positron emission tomography. Neurosci Lett 1992; 137:145-8.
12. 11C]pyrilamine. J Neurochem 1992; 59:128-36.
13. 1 receptor in human brains revealed by PET. Neuroreport 1992; 3:433-6.
14. 1 receptors. Proc Natl Acad Sci USA 1996; 93:13316-20.
15. 1 receptors in mice: behavioral and neurochemical characterization. Proceedings of the 2nd International Symposium on Membrane Receptor-Signaling System. Life Sci 1998; 62:1607-10.
16. 1 receptors. Neuroscience 1998; 87:479-87.
17. 1 receptor occupancy in human subjects treated with epinastine. a second-generation antihistamine. Meth Find Exp Clin Pharmacol 1995; 17:64-9.
18. 1 antagonists measured by positron emission tomography. Br J Pharmacol 1995; 116:1649-55.
19. Hoddes E, Zarcone VP, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychophysiol 1973; 10:431-6.
20. Panula P, Yang HYT, Costa E. Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci USA 1984; 81:2572-6.
21. Watanabe T, Taguchi Y, Shiosaka S, et al. Distribution of the histaminergic neuron system in the central nervous system of rats: a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 1984; 295:13-25.
22. Hill SJ. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol Rev 1990; 42:45-83.
23. Hill SJ, Ganellin CR, Timmerman H, et al. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 1997; 49:253-78.
24. Leurs R, Smit M, Timmerman H. Molecular pharmacolocal aspects of histamine receptors. Pharmac Ther 1995; 66:413-63.
25. Richelson E. Histamine receptors in the central nervous system. In: The Histamine Receptor, Schwartz JC, Haas HL eds. New York: Wiley Liss 1992:271-95.
26. Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M. Histaminergic transmission in the mammalian brain. Physiol Rev 1991; 71:1-51.
27. Onodera K, Yamatodani A, Watanabe T, Wada H. Neuropharmacology of the histamienrgic neuron system in the brain and its relationship with behavioral disorders. Prog Neurobiol 1994; 42:685-702.
28. Jones T. The role of positron emission tomography within the spectrum of medical imaging. Eur J Nucl Med 1996; 23:207-11.
29. Volkow ND, Fowler JS, Gatley SJ, et al. PET evaluation of the dopamine system of the human brain. J Nucl Med 1996; 37:1242-56.
30. Volkow ND, Rosen B, Farde L. Imaging the living human brain: Magnetic resonance imaging and positron emission tomography. Proc Natl Acad Sci USA 1997; 94:2787-8.
31. 1 receptor density with some behavioral effects. Abstr Soc Neurosci 1997; 926.9.
32. 1 receptor activation reduces a background leakage potassium current. Neuroscience 1994; 59:579-88.
33. Okamura N, Yanai K, Higuchi M, et al. Sedative effects of antihistamines in human: A PET investigation. Abstr Soc Neurosci, 1997; 835.1.